BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22985658)

  • 1. Low doses of ranolazine and dronedarone in combination exert potent protection against atrial fibrillation and vulnerability to ventricular arrhythmias during acute myocardial ischemia.
    Verrier RL; Pagotto VP; Kanas AF; Sobrado MF; Nearing BD; Zeng D; Belardinelli L
    Heart Rhythm; 2013 Jan; 10(1):121-7. PubMed ID: 22985658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
    Frommeyer G; Milberg P; Uphaus T; Kaiser D; Kaese S; Breithardt G; Eckardt L
    Cardiovasc Ther; 2013 Dec; 31(6):e63-71. PubMed ID: 23647657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.
    Burashnikov A; Sicouri S; Di Diego JM; Belardinelli L; Antzelevitch C
    J Am Coll Cardiol; 2010 Oct; 56(15):1216-24. PubMed ID: 20883928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrillatory effect of ranolazine during severe coronary stenosis in the intact porcine model.
    Nieminen T; Nanbu DY; Datti IP; Vaz GR; Tavares CA; Pegler JR; Nearing BD; Belardinelli L; Verrier RL
    Heart Rhythm; 2011 Apr; 8(4):608-14. PubMed ID: 21094698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the cardiac late sodium current with eleclazine protects against ischemia-induced vulnerability to atrial fibrillation and reduces atrial and ventricular repolarization abnormalities in the absence and presence of concurrent adrenergic stimulation.
    Justo F; Fuller H; Nearing BD; Rajamani S; Belardinelli L; Verrier RL
    Heart Rhythm; 2016 Sep; 13(9):1860-7. PubMed ID: 27317981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective late sodium current blockade with GS-458967 markedly reduces ischemia-induced atrial and ventricular repolarization alternans and ECG heterogeneity.
    Bonatti R; Silva AF; Batatinha JA; Sobrado LF; Machado AD; Varone BB; Nearing BD; Belardinelli L; Verrier RL
    Heart Rhythm; 2014 Oct; 11(10):1827-35. PubMed ID: 24953379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits.
    Frommeyer G; Kaiser D; Uphaus T; Kaese S; Osada N; Rajamani S; Belardinelli L; Breithardt G; Eckardt L; Milberg P
    Heart Rhythm; 2012 Dec; 9(12):2051-8. PubMed ID: 23044390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapericardial ranolazine prolongs atrial refractory period and markedly reduces atrial fibrillation inducibility in the intact porcine heart.
    Carvas M; Nascimento BC; Acar M; Nearing BD; Belardinelli L; Verrier RL
    J Cardiovasc Pharmacol; 2010 Mar; 55(3):286-91. PubMed ID: 20075744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.
    Kumar K; Nearing BD; Carvas M; Nascimento BC; Acar M; Belardinelli L; Verrier RL
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):796-802. PubMed ID: 19298570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of I(f) in the atrioventricular node as a mechanism for dronedarone's reduction in ventricular rate during atrial fibrillation.
    Verrier RL; Sobrado MF; Pagotto VP; Kanas AF; Machado AD; Varone BB; Sobrado LF; Nearing BD; Zeng D; Belardinelli L
    Heart Rhythm; 2013 Nov; 10(11):1692-7. PubMed ID: 23933296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined effects of ranolazine and dronedarone on human atrial and ventricular electrophysiology.
    Hartmann N; Mason FE; Braun I; Pabel S; Voigt N; Schotola H; Fischer TH; Dobrev D; Danner BC; Renner A; Gummert J; Belardinelli L; Frey N; Maier LS; Hasenfuss G; Sossalla S
    J Mol Cell Cardiol; 2016 May; 94():95-106. PubMed ID: 27056421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism.
    Reiffel JA; Camm AJ; Belardinelli L; Zeng D; Karwatowska-Prokopczuk E; Olmsted A; Zareba W; Rosero S; Kowey P;
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1048-56. PubMed ID: 26226999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion.
    Dhalla AK; Wang WQ; Dow J; Shryock JC; Belardinelli L; Bhandari A; Kloner RA
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1923-9. PubMed ID: 19767532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset atrial fibrillation.
    Fragakis N; Koskinas KC; Katritsis DG; Pagourelias ED; Zografos T; Geleris P
    Am J Cardiol; 2012 Sep; 110(5):673-7. PubMed ID: 22621799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranolazine-induced postrepolarization refractoriness suppresses induction of atrial flutter and fibrillation in anesthetized rabbits.
    Aidonidis I; Doulas K; Hatziefthimiou A; Tagarakis G; Simopoulos V; Rizos I; Tsilimingas N; Molyvdas PA
    J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):94-101. PubMed ID: 22872232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria.
    Sicouri S; Burashnikov A; Belardinelli L; Antzelevitch C
    Circ Arrhythm Electrophysiol; 2010 Feb; 3(1):88-95. PubMed ID: 19952329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranolazine terminates atrial flutter and fibrillation in a canine model.
    Bhimani AA; Yasuda T; Sadrpour SA; Khrestian CM; Lee S; Zeng D; Belardinelli L; Waldo AL
    Heart Rhythm; 2014 Sep; 11(9):1592-9. PubMed ID: 25066042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined actions of ivabradine and ranolazine reduce ventricular rate during atrial fibrillation.
    Verrier RL; Silva AF; Bonatti R; Batatinha JA; Nearing BD; Liu G; Rajamani S; Zeng D; Belardinelli L
    J Cardiovasc Electrophysiol; 2015 Mar; 26(3):329-35. PubMed ID: 25346368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First direct comparison of the late sodium current blocker ranolazine to established antiarrhythmic agents in an ischemia/reperfusion model.
    Kloner RA; Dow JS; Bhandari A
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):192-6. PubMed ID: 21193683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting.
    Miles RH; Passman R; Murdock DK
    Am J Cardiol; 2011 Sep; 108(5):673-6. PubMed ID: 21726841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.